Lukka
VC Fund
New York, United States
Lukka is a technology and data services provider for middle and back-office crypto asset processing. Its crypto-native products connect, standardize, reconcile, process, and report audit-ready information within a highly secure SOC 1 Type 2 enterprise-grade infrastructure. Lukka was founded in 2014 and headquartered in New York, United States.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Lukka invests in
Stages Lukka invests in
Countries Lukka invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Ethereum 1 (33%)
- Biopharma 1 (33%)
- Biotechnology 1 (33%)
- Clinical Trials 1 (33%)
- Network Security 1 (33%)
Stage
- Seed 1 (33%)
- Post-IPO Equity 1 (33%)
- Venture - Series Unknown 1 (33%)
Country
- Israel 1 (33%)
- Bermuda 1 (33%)
- United Kingdom 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alexander Tran
Director of Product
|
Director of Product | Total investments: 0 | Find email | |
Jake Benson
CEO & Founder
|
CEO & Founder | Total investments: 0 | Find email | |
Jeremy Drane
Chief Commercial Officer (CCO)
|
Chief Commercial Officer (CCO) | Total investments: 0 | Find email | |
|
Kinga Bosse
CFO
|
CFO | Total investments: 0 | Find email | |
Melissa Craig
Director, Financial Operations
|
Director, Financial Operations | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Canton Strategic Holdings
|
Hillstream BioPharma is a development-stage company advancing improved therapies for patients with cancer via a unique QUATRAMERTM nanoparticle platform. This unique technology enables intranuclear and intracellular delivery of small molecules, peptides, genes, other macromolecules and biologics to the tumor cello, while significantly minimizingexposure to normal tissues. | $545M / Post-IPO Equity / Nov 03, 2025 | |
SSV Network
|
SSV Network develops a distributed validator technology designed for ETH staking. | $10M / Venture - Series Unknown / Feb 08, 2022 | |
Stablehouse
|
Stablehouse is a payment and FX exchange platform for stablecoins. | $2.2M / Seed / Oct 29, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Lukka invest in?
Lukka invests primarily in Ethereum, Biopharma and Biotechnology startups, most often at Seed and Post-IPO Equity stage. Most of the 3 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Lukka?
Public channels for Lukka include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Lukka?
The team at Lukka includes Alexander Tran (Director of Product), Jake Benson (CEO & Founder) and Jeremy Drane (Chief Commercial Officer (CCO)), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
